You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML-PCZ-UGT1A4 gene

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial in Pierre-Bénite (Posaconazole)

Recruiting
  • Leukemia, Myeloid, Acute
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud, Hematology department
Feb 23, 2022

Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics

Recruiting
  • Gastrointestinal Cancer
  • +4 more
  • Availability of clinical decision support based on pharmacogenomic results.
  • Chicago, Illinois
    University of Chicago Medical Center
Oct 20, 2022

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

Not yet recruiting
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 8, 2022

Trial

Not yet recruiting
  • Leber Hereditary Optic Neuropathy (LHON)
  • NR082 Injection
  • Injection needle
  • (no location specified)
Jan 30, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

HIV-1 Infections Trial in Washington (HAART, T cells)

Completed
  • HIV-1 Infections
  • Washington, District of Columbia
    Walter Reed Army Medical Center
Aug 17, 2022

Spastic Paraplegia Type 50 Trial in Toronto (MELPIDA)

Active, not recruiting
  • Spastic Paraplegia Type 50
  • MELPIDA
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Oct 5, 2023

Disease State in Adult Acute Myeloid Leukemia Ineligible for

Not yet recruiting
  • Acute Myeloid Leukemia
    • Calgary, Alberta, Canada
    • +9 more
    Jun 15, 2022

    People Who Have Genetic Changes and Features of Autism: Simons

    Recruiting
    • 16P11.2 Deletion Syndrome
    • +184 more
      • New York, New York
      • +1 more
      Jan 6, 2023

      Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)

      Recruiting
      • Severe Combined Immunodeficiency Disease, X-linked
      • CL20-i4-EF1α-hγc-OPT
      • +2 more
      • San Francisco, California
      • +2 more
      Jan 9, 2023

      Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Nov 4, 2022

      Fabry Disease Trial in Melbourne, Perth, Taipei (4D-310)

      Active, not recruiting
      • Fabry Disease
      • 4D-310
      • Melbourne, Australia
      • +2 more
      Jan 30, 2023

      LGMDR9 Trial in Copenhagen, Paris, Newcastle Upon Tyne (GNT0006, Day 0: Placebo, Day 0: GNT0006)

      Recruiting
      • LGMDR9
      • GNT0006
      • +4 more
      • Copenhagen, Denmark
      • +2 more
      Oct 21, 2022

      Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Chicago, Illinois
        Northwestern University
      Feb 16, 2023

      Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

      Not yet recruiting
      • Acute Myeloid Leukemia With KMT2A Rearrangement
      • Acute Myeloid Leukemia With NPM1 Mutation
      • Biospecimen Collection
      • +7 more
      • (no location specified)
      Jun 1, 2023

      Advanced Malignant Solid Tumor, Cholangiocarcinoma, Metastatic Malignant Solid Tumor Trial in Columbus (Infigratinib)

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Feb 15, 2022

      Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

      Recruiting
      • Metastatic Malignant Solid Neoplasm
      • Unresectable Malignant Solid Neoplasm
      • Biopsy
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Jan 25, 2023

      FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

      Active, not recruiting
      • FLT3 Gene Mutation Negative
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 16, 2022

      Hereditary Angioedema, HAE Trial in United States (Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331)

      Recruiting
      • Hereditary Angioedema
      • HAE
      • Dose 1 of BMN 331
      • +4 more
      • Birmingham, Alabama
      • +11 more
      Jan 26, 2023

      Advanced Solid Tumor, Metastatic Solid Tumor, NSCLCs Trial (PRT3789)

      Recruiting
      • Advanced Solid Tumor
      • +3 more
      • Fairfax, Virginia
        NEXT Virginia
      Feb 1, 2023

      Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

      Withdrawn
      • Recurrent Acute Myeloid Leukemia
      • Bosutinib Monohydrate
      • +6 more
      • Duarte, California
        City of Hope Meidcal Center
      Jun 7, 2022

      Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
      • Cincinnati, Ohio
      • +18 more
      Jan 20, 2023

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      Apr 10, 2023